These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma. Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of primary cerebral lymphoma]. Delwail V; Bataille B Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617 [TBL] [Abstract][Full Text] [Related]
5. [Treatment results of intra-arterial ACNU infusion chemotherapy for primary cerebral malignant lymphoma]. Hayashi A; Kyuma Y; Chiba Y; Kuwana N; Kojima Y Gan To Kagaku Ryoho; 1993 Jun; 20(8):1043-7. PubMed ID: 8512332 [TBL] [Abstract][Full Text] [Related]
6. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571 [TBL] [Abstract][Full Text] [Related]
7. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. Weller M; Müller B; Koch R; Bamberg M; Krauseneck P; J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063 [TBL] [Abstract][Full Text] [Related]
8. Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Fliessbach K; Urbach H; Helmstaedter C; Pels H; Glasmacher A; Kraus JA; Klockgether T; Schmidt-Wolf I; Schlegel U Arch Neurol; 2003 Apr; 60(4):563-8. PubMed ID: 12707070 [TBL] [Abstract][Full Text] [Related]
9. [Primary central nervous system lymphoma--a report of 32 cases with literature review]. Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684 [TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system. Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803 [TBL] [Abstract][Full Text] [Related]
11. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608 [TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853 [TBL] [Abstract][Full Text] [Related]
13. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients. Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of methotrexate in cerebrospinal fluid and serum after osmotic blood-brain barrier disruption in patients with brain lymphoma. Zylber-Katz E; Gomori JM; Schwartz A; Lossos A; Bokstein F; Siegal T Clin Pharmacol Ther; 2000 Jun; 67(6):631-41. PubMed ID: 10872645 [TBL] [Abstract][Full Text] [Related]
15. High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962. Poortmans PM; Kluin-Nelemans HC; Haaxma-Reiche H; Van't Veer M; Hansen M; Soubeyran P; Taphoorn M; Thomas J; Van den Bent M; Fickers M; Van Imhoff G; Rozewicz C; Teodorovic I; van Glabbeke M; J Clin Oncol; 2003 Dec; 21(24):4483-8. PubMed ID: 14597741 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of primary intracranial lymphoma]. Yu SQ; Zhao JZ; Lu Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):657-8. PubMed ID: 12901119 [TBL] [Abstract][Full Text] [Related]
18. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. Shah GD; Yahalom J; Correa DD; Lai RK; Raizer JJ; Schiff D; LaRocca R; Grant B; DeAngelis LM; Abrey LE J Clin Oncol; 2007 Oct; 25(30):4730-5. PubMed ID: 17947720 [TBL] [Abstract][Full Text] [Related]
19. [Clinical study of primary central nervous system lymphoma: the role of chemotherapy]. Maeda Y; Matsumoto K; Kuriyama M; Ono Y; Kunishio K; Tamiya T; Furuta T; Ohmoto T Gan To Kagaku Ryoho; 1997 May; 24(7):807-13. PubMed ID: 9170518 [TBL] [Abstract][Full Text] [Related]
20. Primary T-cell lymphoma of the brain in children: a case report and literature review. al-Ghamdi H; Sabbah R; Martin J; Patay Z Pediatr Hematol Oncol; 2000 Jun; 17(4):341-3. PubMed ID: 10845234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]